BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7812946)

  • 21. An overview of the clinical and molecular genetics of Wilms' tumor.
    Grundy P; Coppes M
    Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
    [No Abstract]   [Full Text] [Related]  

  • 22. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional properties of WT1.
    Haber DA; Englert C; Maheswaran S
    Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 gene mutation spectrum in human unknown primary tumors.
    Bar-Eli M; Abbruzzese JL; Lee-Jackson D; Frost P
    Anticancer Res; 1993; 13(5A):1619-23. PubMed ID: 8239543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics of Wilms' tumor: insights into normal and abnormal renal development.
    Pelletier J
    Can J Oncol; 1994 Apr; 4(2):262-72. PubMed ID: 8004410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
    Habuchi T; Takahashi R; Yamada H; Ogawa O; Kakehi Y; Ogura K; Hamazaki S; Toguchida J; Ishizaki K; Fujita J
    Cancer Res; 1993 Aug; 53(16):3795-9. PubMed ID: 8339293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
    Oda H; Nakatsuru Y; Ishikawa T
    Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
    Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
    J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor.
    Defavery R; Lemos JA; Kashima S; Bernardes JE; Scridelli CA; Covas DT; Tone LG
    Sao Paulo Med J; 2000 Mar; 118(2):49-52. PubMed ID: 10772697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gene expression signature for relapse of primary wilms tumors.
    Li W; Kessler P; Yeger H; Alami J; Reeve AE; Heathcott R; Skeen J; Williams BR
    Cancer Res; 2005 Apr; 65(7):2592-601. PubMed ID: 15805255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of Wilms' tumor.
    Coppes MJ; Egeler RM
    Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail.
    Strickler JG; Zheng J; Shu Q; Burgart LJ; Alberts SR; Shibata D
    Cancer Res; 1994 Sep; 54(17):4750-5. PubMed ID: 8062274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
    Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
    Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.
    Peng H; Chen G; Du M; Singh N; Isaacson PG; Pan L
    Am J Pathol; 1996 Feb; 148(2):643-8. PubMed ID: 8579126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.